
Safety and Effectiveness of the Hyaluronic Acid Dermal Filler VYC-17.5L for Nasolabial Folds: Results of a Randomized, Controlled Study
Author(s) -
Gary D. Monheit,
Kenneth Beer,
Bhushan Hardas,
Pearl E. Grimes,
Barry M. Weichman,
Vince Lin,
Diane K. Murphy
Publication year - 2018
Publication title -
dermatologic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.659
H-Index - 125
eISSN - 1524-4725
pISSN - 1076-0512
DOI - 10.1097/dss.0000000000001529
Subject(s) - medicine , hyaluronic acid , randomized controlled trial , surgery , nasolabial fold , clinical endpoint , physical therapy , anatomy
Juvéderm Vollure XC (VYC-17.5L) belongs to a family of nonanimal hyaluronic acid (HA) gels based on the Vycross technology platform.